Showing results (351-360 of 689) with videos related to
Sort By:
Pageof 69
Journal of Cardiovascular Pharmacology and Therapeutics|September 26, 2013
Circadian variation of stent thrombosis and the effect of more robust platelet inhibition: a post hoc analysis of the TRITON-TIMI 38 trialOwen Mogabgab, Stephen D Wiviott, Christopher P Cannon, et al.American Heart Journal|June 1, 2002
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromesRichard C Becker, Frederick A Spencer, Michael Gibson, et al.American Heart Journal|August 25, 2009
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudyYuri B Pride, Stephen D Wiviott, Jacqueline L Buros, et al.American Heart Journal|August 31, 2000
Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogramJ A De Lemos, E M Antman, R P Giugliano, et al.Journal of the American College of Cardiology|November 25, 2000
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudyD A Morrow, E M Antman, M Tanasijevic, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patientsJ P Eder, A D Elias, L Ayash, et al.BMJ Open|November 10, 2023
Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USAJulie C Lauffenburger, Helen Tesfaye, Daniel H Solomon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantationC Hesdorffer, J Ayello, M Ward, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcomeA Elias, J Ibrahim, A T Skarin, et al.International Journal of Cardiology|January 12, 2008
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromesShaheeda Ahmed, Christopher P Cannon, Robert P Giugliano, et al.Pageof 69